User:Shireen Rudina: Difference between revisions
| (8 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
==Contact Info== | ==Contact Info== | ||
*Shireen Rudina | *Shireen Rudina | ||
* | *srudinaATstanfordDOTedu. | ||
* | *srudinaATalumDOTmitDOTedu | ||
*[[Special:Emailuser/Shireen Rudina|Email me through OpenWetWare]] | *[[Special:Emailuser/Shireen Rudina|Email me through OpenWetWare]] | ||
==Education== | ==Education== | ||
<!--Include info about your educational background--> | <!--Include info about your educational background--> | ||
* 2013, BS in Biological Engineering, MIT | * Currently graduate student (PhD track) in Bioengineering at Stanford University | ||
* Feb 2013, BS in Biological Engineering, MIT | |||
==Research interests== | ==Research interests== | ||
<!-- Feel free to add brief descriptions to your research interests as well --> | <!-- Feel free to add brief descriptions to your research interests as well --> | ||
* Synthetic biology | |||
* Gene Therapy | |||
I | During the summer of 2012 and Feb-June 2013, I was a full-time Organism Engineering intern at [[www.ginkgobioworks.com| Ginkgo Bioworks]]. | ||
From Jan-Dec 2012, I worked Dr. Chris Voigt's lab at MIT with Felix Moser, where I was working on improving the dynamic range of sensors in genetic circuits through the use of plasmid copy number. | From Jan-Dec 2012, I worked Dr. Chris Voigt's lab at MIT with Felix Moser, where I was working on improving the dynamic range of sensors in genetic circuits through the use of plasmid copy number. | ||
| Line 30: | Line 30: | ||
<!-- Replace the PubMed ID's ("pmid=#######") below with the PubMed ID's for your publications. You can add or remove lines as needed --> | <!-- Replace the PubMed ID's ("pmid=#######") below with the PubMed ID's for your publications. You can add or remove lines as needed --> | ||
== | <biblio> | ||
#Paper1 Gupton et al. Mena binds α5 integrin directly and modulates α5β1 function. pmid= 22908313 | |||
#Paper2 Ciolino et al. In vivo performance of a drug-eluting contact lens to treat glaucoma for a month. pmid= 24094935 | |||
Latest revision as of 11:23, 22 March 2014
Contact Info
- Shireen Rudina
- srudinaATstanfordDOTedu.
- srudinaATalumDOTmitDOTedu
- Email me through OpenWetWare
Education
- Currently graduate student (PhD track) in Bioengineering at Stanford University
- Feb 2013, BS in Biological Engineering, MIT
Research interests
- Synthetic biology
- Gene Therapy
During the summer of 2012 and Feb-June 2013, I was a full-time Organism Engineering intern at Ginkgo Bioworks.
From Jan-Dec 2012, I worked Dr. Chris Voigt's lab at MIT with Felix Moser, where I was working on improving the dynamic range of sensors in genetic circuits through the use of plasmid copy number.
From Sept 2010- Dec 2011, I worked in the Lauffenburger lab at MIT with Dr. Shannon Alford designing an ELISA assay for Mena, a protein upregulated in invasive breast cancer cells. Previously, I studied how the variation in ECM proteins affects the migration and adhesion of invasive breast cancer cells.
During the summer of 2011, I was an Amgen Scholar at Stanford University, and did research in Prof. Christina Smolke's lab with Isis Trenchard, working to engineer S. cerevisiae for the production of bisbenzylisoquinoline alkaloids.
I have also worked on developing a drug-eluting contact lens with Dr. Joe Ciolino in the Langer lab at MIT during January-August 2010.
Publications
<biblio>
- Paper1 Gupton et al. Mena binds α5 integrin directly and modulates α5β1 function. pmid= 22908313
- Paper2 Ciolino et al. In vivo performance of a drug-eluting contact lens to treat glaucoma for a month. pmid= 24094935
